Altamira Therapeutics Ltd. (NASDAQ:CYTO) Q2 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Altamira Therapeutics First Half 2024 and Business Update Conference Call.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 2. | Armistice Capital Steven Boyd | 0 | $0 | 0% |